These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 21883139)

  • 1. Chronic lymphocytic leukaemia responsive to vitamin D administration.
    Arlet JB; Callens C; Hermine O; Darnige L; Macintyre E; Pouchot J; Capron L
    Br J Haematol; 2012 Jan; 156(1):148-9. PubMed ID: 21883139
    [No Abstract]   [Full Text] [Related]  

  • 2. Fludarabine for chronic lymphocytic leukemia.
    Erman M; Celik I; Tekuzman G
    N Engl J Med; 2001 Apr; 344(15):1166; author reply 1167-8. PubMed ID: 11302142
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fludarabine in the treatment of chronic lymphocytic leukemia and other lymphoproliferative disorders].
    Pawelski S
    Acta Haematol Pol; 1995; 26(3):263-8. PubMed ID: 8525771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When and how to treat chronic lymphocytic leukemia.
    Dighiero G; Binet JL
    N Engl J Med; 2000 Dec; 343(24):1799-801. PubMed ID: 11114321
    [No Abstract]   [Full Text] [Related]  

  • 5. High-dose methylprednisolone can induce remissions in patients with fludarabine-refractory chronic lymphocytic leukaemia.
    Xu W; Miao KR; Hong M; Zhu DX; Fang C; Dong HJ; Wang DM; Cao X; Li JY
    Eur J Cancer; 2010 Aug; 46(12):2145-9. PubMed ID: 20627536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.
    Rai KR; Peterson BL; Appelbaum FR; Kolitz J; Elias L; Shepherd L; Hines J; Threatte GA; Larson RA; Cheson BD; Schiffer CA
    N Engl J Med; 2000 Dec; 343(24):1750-7. PubMed ID: 11114313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D insufficiency predicts time to first treatment (TFT) in early chronic lymphocytic leukemia (CLL).
    Molica S; Digiesi G; Antenucci A; Levato L; Mirabelli R; Molica M; Gentile M; Giannarelli D; Sperduti I; Morabito F; Conti L
    Leuk Res; 2012 Apr; 36(4):443-7. PubMed ID: 22047708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cladribine for the treatment of hairy cell leukemia and chronic lymphocytic leukemia.
    Rai KR
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):19-22. PubMed ID: 9671325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fludarabine therapy in chronic lymphocytic leukemia-associated severe nephrotic syndrome.
    Abdel-Raheem MM; Jamil MG; Potti A; Gross GG
    Haematologica; 2000 Nov; 85(11):1224-5. PubMed ID: 11064479
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent developments in the treatment of CLL.
    Cheson BD
    Clin Adv Hematol Oncol; 2008 May; 6(5):6-8; quiz 10-2. PubMed ID: 18578096
    [No Abstract]   [Full Text] [Related]  

  • 11. Fludarabine for chronic lymphocytic leukemia.
    Copur MS; Ledakis P; Muhvic J
    N Engl J Med; 2001 Apr; 344(15):1166; author reply 1167-8. PubMed ID: 11302141
    [No Abstract]   [Full Text] [Related]  

  • 12. Simultaneous occurrence of chronic lymphocytic leukaemia and acute lymphoblastic leukaemia.
    Bueno J; Irriguible MD; Palacio C
    Haematologica; 2002 Apr; 87(4):EIM11. PubMed ID: 11940498
    [No Abstract]   [Full Text] [Related]  

  • 13. [Successful treatment with fludarabine of chronic lymphocytic leukemia associated with nephrotic syndrome].
    Takei K; Horikoshi A; Hosokawa Y; Sawada S; Horie T
    Rinsho Ketsueki; 2002 Nov; 43(11):993-7. PubMed ID: 12508485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic lymphatic leukemia. Peroral cladribine as primary treatment].
    Gjedde SB; Juliusson G; Hansen MM
    Ugeskr Laeger; 1996 Nov; 158(45):6432-4. PubMed ID: 8992677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune neutropenia following therapy for chronic lymphocytic leukaemia: a report of three cases.
    Roberts L; Lucas G; Green L; Lindsay J; Bhattacharyya S; Thornton P; Evans G; Pocock C
    Br J Haematol; 2007 Jan; 136(2):348-9. PubMed ID: 17156393
    [No Abstract]   [Full Text] [Related]  

  • 16. Lenalidomide can be highly effective in chronic lymphocytic leukaemia despite T-cell depletion and deletion of chromosome 17p.
    Arumainathan A; Kalakonda N; Pettitt AR
    Eur J Haematol; 2011 Oct; 87(4):372-5. PubMed ID: 21679253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of a patient with chronic lymphocytic leukaemia (CLL) presenting with bony metastases with aggressive antibody and chemotherapy.
    Narayan H; Bandyopadhyay D; Schmidt K; Chachlani N; Hughes M; Paneesha S; Rose P; Borg A
    Clin Lab Haematol; 2005 Dec; 27(6):405-8. PubMed ID: 16307545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines on the diagnosis and management of chronic lymphocytic leukaemia.
    Oscier D; Fegan C; Hillmen P; Illidge T; Johnson S; Maguire P; Matutes E; Milligan D;
    Br J Haematol; 2004 May; 125(3):294-317. PubMed ID: 15086411
    [No Abstract]   [Full Text] [Related]  

  • 19. 2-Chlorodeoxyadenosine, a "novel" agent in the treatment of both lymphoid and myeloid malignancies.
    Lauria F
    Haematologica; 1992; 77(6):443-5. PubMed ID: 1363233
    [No Abstract]   [Full Text] [Related]  

  • 20. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
    Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
    Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.